Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NAMENDA
- Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
- Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury
- Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
- Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
- NTS-WBRT VS HA-WBRT in Brain Metastases
- A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
- Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
- Memantine in Body Focused Repetitive Behaviors
- Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
- Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
- Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
- Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
- Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
- Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
- Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
- SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
- Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
- Down Syndrome Memantine Follow-up Study
- An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress Disorder
- Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury
- Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia
- Impact of Persistent Conductances on Motor Unit Firing in SCI
- Therapy in Amyotrophic Lateral Sclerosis (TAME)
- Open-label Study of Safety and Tolerability of Memantine in Children With Autism
- Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
- Brain Aging and Treatment Response in Geriatric Depression
- Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
- Memantine Monotherapy for Executive Dysfunction and ADHD
- Attenuation of Corticosteroid Induced Hippocampal Changes
- An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
- Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
- Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
- Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking
- Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
- A Trial of Memantine as Symptomatic Treatment for Early Huntington Disease
- Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
- A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)
- A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders
- Memantine for Recurrent Glioblastoma
- Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
- Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
- Memantine for Post-Operative Pain Control
- An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
- The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
- Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy
- Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
- Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease
- Memantine in the Treatment of Kleptomania
- Memantine Treatment of Compulsive Buying
- Corticolimbic Degeneration and Treatment of Dementia
- Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
- Study of Memantine to Treat Huntington's Disease
- Namenda (Memantine) for Non-Motor Symptoms in Parkinson's Disease
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Memantine for Spasticity in MS Patients
- Family History Study of Alcohol Consumption Using Memantine
- Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS
- Memantine and Cognitive Dysfunction in Bipolar Disorder
- Memantine Treatment Study of Pathological Gambling
- Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
- Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
- Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury
- A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
- Memantine Augmentation of Antidepressants
- Namenda to Prevent Post-Operative Delirium
- Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
- Memantine Augmentation in Obsessive-Compulsive Disorder
- Treatment of Orthostatic Intolerance
- The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
- Treatment With Namenda in Women at Risk for Cognitive Decline
- A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
- A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
- Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
- Memantine in Systemic Lupus Erythematosus
- Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Clinical trials list
click for details